Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination - Top-Institutions - DentalSpire

Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination

  • By

  • Stina Gröhn

  • Heini Lehto

  • Saana Soppela

  • Rauno A. Naves

  • Mikael A. Ritvos

  • Alina Iakubovskaia

  • Vili Lampinen

  • Iiris Mustonen

  • Sanniina Pakkala

  • Elizaveta Husu

  • Laura Kakkola

  • Ilkka Julkunen

  • Pekka Kolehmainen

  • Arja Pasternack

  • Olli Ritvos

  • Minna M. Hankaniemi

  • January 29, 2026

  • 0 min

Share

Top Institutions in Dental

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Vaccine Development

  • #2

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Virology
    • Immunology
    • Clinical Trials

  • #3

    Massachusetts Institute of Technology (MIT)
    Massachusetts Institute of Technology (MIT)

    Cambridge, MA

    Key Differentiators

    • Biomedical Engineering
    • Immunoengineering
    • Vaccine Technology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Clinical Research

  • #5

    National Institute of Allergy and Infectious Diseases (NIAID)
    National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Virology
    • Vaccine Research

Original Source(s)

Nucleocapsid Protein Boosts Humoral and Cellular Immune Responses Specific to Spike and RBD in Protein-Based SARS-CoV-2 Vaccination

  • by Stina Gröhn, Heini Lehto, Saana Soppela, Rauno A. Naves, Mikael A. Ritvos, Alina Iakubovskaia, Vili Lampinen, Iiris Mustonen, Sanniina Pakkala, Elizaveta Husu, Laura Kakkola, Ilkka Julkunen, Pekka Kolehmainen, Arja Pasternack, Olli Ritvos, Minna M. Hankaniemi

  • January 29, 2026

Related Content

COVID-19 Reinfections in the City of São Paulo, Brazil: Prevalence and Socioeconomic Factors

Increased Depression and Anxiety Among Men and Transgender Women Receiving Care at a Sexual Health Clinic in New York City During COVID-19

Epidemiological Trends of Hand, Foot, and Mouth Disease Across Three Distinct Periods in Jiangxi Province, China: A Retrospective Analysis from 2009 to 2022